[VIDEO] Radiology is at a crossroads and the first issue to be dealt with is change, says Sanjay Jain, MD, MBA.
“We have to learn to understand what’s going on in the market and adapt those changes,” Sanjay Jain, MD, MBA, said at AHRA 2014.
Change, he said, is the biggest problem facing radiology today. Radiology has seen its fair share of changes in areas like regulation, reimbursement, workforce, and staffing. And the radiology industry needs to learn to adapt, he said.
Decreasing reimbursements, consolidation, and commoditization with private equity and hospitals buying out radiology are the heavy hitting changes radiology is facing today, Jain said. “[Radiologists] are now becoming employees, or retiring early,” he said.
It’s not all doom and gloom, though. Jain said the perceived job shortage, which has been a major point of concern, has been leveling off. “It’s all about weathering the storm,” he said.
The changes facing radiology, though discouraging, may also encourage new business models and ideas.
In Jain’s session on the need to reinvent radiology at AHRA 2014, he mentions the benefit of “Blue Ocean Strategy” in radiology. Blue Ocean Strategy is a concept that has been historically taught in business schools, Jain said. The premise in radiology is to shift the focus from the current market to creating new markets where there is no competition.
“It’s a strategic concept that requires thinking outside of the box,” Jain said.
Jain is optimistic about the future of radiology, in the long-term. The short-term future looks pretty murky, though, he said.
“We just started Obamacare this year so we haven’t let it mature and see how it’s going to impact radiology,” he said.
With the uncertainty of Obamacare and the Affordable Care Act’s effects on radiology, the field is primed to see more changes in the short-term future.
“We just have to buckle up and manage those changes,” Jain said.
While tough times may be ahead, Jain urges that radiology is a type of grand central station, with many other specialties coming through radiology for consultation.
“That’s pretty powerful,” Jain said. “[Radiologists] need to harness that power and take advantage of it.”
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.